ANI Pharmaceuticals | ANIP - Equity Capital And Reserves


ANI Pharmaceuticals reported $540.72M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
AbbVie USD -3.27B 628M Dec/2025
ANI Pharmaceuticals USD 540.72M 34.91M Dec/2025
Assertio Holdings USD 105.8M 12.5M Sep/2025
Aurora Cannabis CAD 536.36M 30.74M Dec/2025
Canopy Growth CAD 758.17M 22.16M Dec/2025
Eli Lilly USD 26.54B 2.74B Dec/2025
Emergent BioSolutions USD 649.3M 47.9M Dec/2023
Heron Therapeutics USD 13.28M 1.6M Dec/2025
Hikma Pharmaceutical USD 2.59B 42M Dec/2025
Knight Therapeutics CAD 767.27M 480K Dec/2025
Nektar Therapeutics USD 89.83M 4.75M Dec/2025
Novartis USD 46.13B 1.8B Dec/2025
Omeros USD -228.68M 15.13M Jun/2025
Perrigo USD 2.94B 1.51B Dec/2025
Sun Pharmaceuticals INR 778.2B 56.02B Sep/2025
Teva Pharmaceutical Industries USD 7.91B 664M Dec/2025